Wishing you a safe and successful 2023!
NEWS & EVENTS
IDDI APPOINTS LINDA DANIELSON AS ITS NEW CHIEF EXECUTIVE OFFICER
IDDI announces the appointment of Linda Danielson as the Company’s new Chief Executive Officer (CEO), effective January 1, 2023. She succeeds Damien Tremolet, CEO since 2009, who will continue to serve as Executive Chairman of the Board of IDDI.
IDDI AT JP MORGAN CONFERENCE
Shruti Jituri, IDDI‘s Director Business Development, Western USA will be at the San Francisco Marriott Marquis during the JPM Week. Schedule a meeting with her to discuss how IDDI can help deliver successful clinical trials for your next drug development projects!
UPCOMING WEBINAR
THE ADDED VALUE OF BIOSTATISTICS-DRIVEN RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEM
January 25, 2023 | 9pm CET/ 9am EDT
In this joint IDDI/CLARIO case study-focused webinar, the speakers will highlight how biostatistics is crucial at multiple stages of clinical trials such as study design, randomization implementation, rerandomization needs, randomization and drug supply checks, unblinding and final analysis.
Register to learn:
- How combined advanced biostatistics and innovative integrated randomization and trial supply management system (RTSM) solutions can increase efficiency and mitigate risks throughout the drug development process
- How complex studies benefit from close collaboration between biostatistics experts and RTSM specialists at study design, study set-up (including trial supply optimization) and managing mid-study changes
Speakers:
- Paul Vanbosterhaut, Sr. RTSM System Specialist, IDDI
- Anthony Warren, Director, Technical Product Management, Clario
ON-DEMAND WEBINARS
Why Do So many Phase 3 Trials Fail? Learn on statistical explanations for a large proportion of Phase III clinical trials failures, and how to address both the overestimation of treatment effects, and the misinterpretation of P-values via Bayesian methods.
Optimizing Rare Diseases Trials: Trial Design & Trial Execution:
Gain insights into trial design and execution strategies to optimize rare disease trials!
- Trial design: an innovative statistical method enabling you to leverage higher power of data with smaller sample sizes.
- Trial execution: providing insights on how to maximize operational efficiencies in rare disease trials through feasibility, regulatory and enrollment phases.
ALL THE RECORDINGS AND PRESENTATIONS OF OUR WEBINARS ARE AVAILABLE ON OUR IDDI WEBINAR WEBPAGE.
DID YOU KNOW?
IDDI can set up your eCRF in both ID-base™ (powered by EvidentIQ), an EDC system ‘designed BY investigators FOR investigators‘ and Rave EDC System (powered by Medidata).
When your EDC is set-up with ID-base:
DID YOU KNOW THAT ANY OF YOUR ONLINE REPORT COULD BE DISPLAYED ON THE ID-BASE HOMEPAGE FOR FREE?
CONFERENCES & MEETINGS
We look forward to meeting you at those conferences and discuss your needs for your upcoming trials. We combine advanced biostatistics, regulatory and medical expertise, and innovative integrated eClinical solutions to increase efficiency and mitigate risks throughout the drug development process.
- 9 – 12 JAN: JP Morgan Conference – San Francisco, CA, USA | Meet Shruti Jituri
- 21 – 22 FEB: Clinical Outsourcing Group – UK – London UK | Meet Erik Falvey at Booth 8
- 1 – 2 MAR: Outsourcing in Clinical Trial West Coast – Burlingame, CA, USA | Meet Shruti Jituri
- 28 – 29 MAR: Outsourcing in Clinical Trials Southeast – Durham, NC USA | Meet Shruti Jituri at Booth 27!
HR NEWS
WE KEEP ON GROWING – WE KEEP ON HIRING!
We are looking for talents to join our growing team in Belgium and the USA! Are you ready for new challenges in helping biotech and pharma companies develop new drugs and treatments? Apply today!
JOIN OUR INNOVATIVE AND GROWING TEAM – WE ARE HIRING!